IL85220A - Precursor protein of apc polypeptide and dna coding therefor - Google Patents
Precursor protein of apc polypeptide and dna coding thereforInfo
- Publication number
- IL85220A IL85220A IL85220A IL8522088A IL85220A IL 85220 A IL85220 A IL 85220A IL 85220 A IL85220 A IL 85220A IL 8522088 A IL8522088 A IL 8522088A IL 85220 A IL85220 A IL 85220A
- Authority
- IL
- Israel
- Prior art keywords
- precursor protein
- dna coding
- coding therefor
- apc polypeptide
- fragments
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Neurology (AREA)
- General Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19873702789 DE3702789A1 (de) | 1987-01-30 | 1987-01-30 | Vorlaeuferprotein des apc-polypeptids, dafuer codierende dna und diagnostische verwendung der dna und des proteins |
Publications (2)
Publication Number | Publication Date |
---|---|
IL85220A0 IL85220A0 (en) | 1988-07-31 |
IL85220A true IL85220A (en) | 1993-07-08 |
Family
ID=6319874
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL85220A IL85220A (en) | 1987-01-30 | 1988-01-27 | Precursor protein of apc polypeptide and dna coding therefor |
Country Status (16)
Country | Link |
---|---|
US (1) | US5218100A (xx) |
EP (1) | EP0276723B1 (xx) |
JP (2) | JP2783407B2 (xx) |
KR (1) | KR960011524B1 (xx) |
CN (1) | CN1034576C (xx) |
AT (1) | ATE98260T1 (xx) |
AU (1) | AU603179B2 (xx) |
CA (1) | CA1341033C (xx) |
DE (2) | DE3702789A1 (xx) |
DK (1) | DK47588A (xx) |
ES (1) | ES2061527T3 (xx) |
HU (1) | HUT46356A (xx) |
IL (1) | IL85220A (xx) |
NZ (1) | NZ223312A (xx) |
PH (1) | PH25795A (xx) |
ZA (1) | ZA88634B (xx) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1339014C (en) * | 1987-10-08 | 1997-03-25 | Ronald E. Majocha | Antibodies to a4 amyloid peptide |
US5015570A (en) * | 1988-05-13 | 1991-05-14 | Molecular Therapeutics, Inc. | Molecular diagnosis of Alzheimer Disease |
JPH03239595A (ja) * | 1990-02-16 | 1991-10-25 | Dainippon Printing Co Ltd | カード製造方法 |
ATE286971T1 (de) * | 1991-01-21 | 2005-01-15 | Elan Pharm Inc | Prüfung und modell für alzheimers-krankheit |
US5455169A (en) | 1992-06-04 | 1995-10-03 | Alzheimer's Institute Of America, Inc. | Nucleic acids for diagnosing and modeling Alzheimer's disease |
US5872101A (en) * | 1995-01-06 | 1999-02-16 | Sibia Neurosciences, Inc. | Methods of treating neurodegenerative disorders using protease inhibitors |
US5804560A (en) * | 1995-01-06 | 1998-09-08 | Sibia Neurosciences, Inc. | Peptide and peptide analog protease inhibitors |
EP1030925A1 (en) | 1997-11-12 | 2000-08-30 | Brigham & Women's Hospital, Inc. | The translation enhancer element of the human amyloid precursor protein gene |
US6750324B1 (en) | 1997-12-02 | 2004-06-15 | Neuralab Limited | Humanized and chimeric N-terminal amyloid beta-antibodies |
TWI239847B (en) | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
US6761888B1 (en) | 2000-05-26 | 2004-07-13 | Neuralab Limited | Passive immunization treatment of Alzheimer's disease |
US6787523B1 (en) | 1997-12-02 | 2004-09-07 | Neuralab Limited | Prevention and treatment of amyloidogenic disease |
US6923964B1 (en) | 1997-12-02 | 2005-08-02 | Neuralab Limited | Active immunization of AScr for prion disorders |
US20080050367A1 (en) | 1998-04-07 | 2008-02-28 | Guriq Basi | Humanized antibodies that recognize beta amyloid peptide |
US6905686B1 (en) | 1997-12-02 | 2005-06-14 | Neuralab Limited | Active immunization for treatment of alzheimer's disease |
US6710226B1 (en) | 1997-12-02 | 2004-03-23 | Neuralab Limited | Transgenic mouse assay to determine the effect of Aβ antibodies and Aβ Fragments on alzheimer's disease characteristics |
US6913745B1 (en) | 1997-12-02 | 2005-07-05 | Neuralab Limited | Passive immunization of Alzheimer's disease |
US20030147882A1 (en) | 1998-05-21 | 2003-08-07 | Alan Solomon | Methods for amyloid removal using anti-amyloid antibodies |
WO2000002911A2 (en) * | 1998-07-10 | 2000-01-20 | Curagen Corporation | INTERACTION OF HUMAN BETA AMYLOID PRECURSOR PROTEIN (β-APP) WITH HUMAN LON-PROTEASE LIKE PROTEIN (HSLON) |
US6787637B1 (en) | 1999-05-28 | 2004-09-07 | Neuralab Limited | N-Terminal amyloid-β antibodies |
UA81216C2 (en) | 1999-06-01 | 2007-12-25 | Prevention and treatment of amyloid disease | |
US7196163B2 (en) * | 2001-05-22 | 2007-03-27 | Merk & Co., Inc. | Assays using amyloid precursor proteins with modified β-secretase cleavage sites to monitor β-secretase activity |
KR100900541B1 (ko) | 2002-11-14 | 2009-06-02 | 삼성전자주식회사 | 액정 표시 장치용 박막 트랜지스터 기판 |
DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
JP2008523815A (ja) | 2004-12-15 | 2008-07-10 | エラン ファーマ インターナショナル リミテッド | 認知の改善における使用のためのヒト化アミロイドβ抗体 |
CA2631195C (en) | 2005-11-30 | 2016-04-05 | Abbott Laboratories | Monoclonal antibodies against amyloid beta protein and uses thereof |
CN101432302A (zh) | 2005-11-30 | 2009-05-13 | 艾博特公司 | 抗-Aβ球聚体抗体,其抗原结合部分,相应的杂交瘤、核酸、载体、宿主细胞,生产所述抗体的方法,包含所述抗体的组合物,所述抗体的应用以及使用所述抗体的方法 |
PT2361638E (pt) * | 2005-12-12 | 2014-04-17 | Ac Immune Sa | Anticorpos monoclonais específicos beta 1-42 com propriedades terapêuticas |
EP2046833B9 (en) | 2006-07-14 | 2014-02-19 | AC Immune S.A. | Humanized antibody against amyloid beta |
US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
AR064501A1 (es) * | 2006-12-22 | 2009-04-08 | Genentech Inc | Antagonistas del dr6 (receptor de muerte 6) y usos de los mismos en el tratamiento de trastornos neurologicos |
EP2124952A2 (en) | 2007-02-27 | 2009-12-02 | Abbott GmbH & Co. KG | Method for the treatment of amyloidoses |
US8048420B2 (en) | 2007-06-12 | 2011-11-01 | Ac Immune S.A. | Monoclonal antibody |
PE20090766A1 (es) * | 2007-06-12 | 2009-07-09 | Ac Immune Sa | Anticuerpo igg1 humanizado |
US8613923B2 (en) | 2007-06-12 | 2013-12-24 | Ac Immune S.A. | Monoclonal antibody |
CA2701793C (en) * | 2007-10-05 | 2017-04-25 | Genentech, Inc. | Use of anti-amyloid beta antibody in ocular diseases |
SG178809A1 (en) * | 2007-10-05 | 2012-03-29 | Genentech Inc | Use of anti-amyloid beta antibody in ocular diseases |
JO3076B1 (ar) | 2007-10-17 | 2017-03-15 | Janssen Alzheimer Immunotherap | نظم العلاج المناعي المعتمد على حالة apoe |
KR20110028504A (ko) * | 2008-06-12 | 2011-03-18 | 제넨테크, 인크. | 신경변성을 억제하는 화합물의 스크리닝 방법 |
US9067981B1 (en) | 2008-10-30 | 2015-06-30 | Janssen Sciences Ireland Uc | Hybrid amyloid-beta antibodies |
EA201190025A1 (ru) | 2008-11-25 | 2012-12-28 | Байоджен Айдек Ма Инк. | ПРИМЕНЕНИЕ АНТАГОНИСТОВ DR6 И p75 ДЛЯ ПРОМОТИРОВАНИЯ ВЫЖИВАНИЯ КЛЕТОК НЕРВНОЙ СИСТЕМЫ |
AR078986A1 (es) * | 2009-11-12 | 2011-12-14 | Genentech Inc | Un metodo para promover la densidad de espinas dendriticas |
US8987419B2 (en) | 2010-04-15 | 2015-03-24 | AbbVie Deutschland GmbH & Co. KG | Amyloid-beta binding proteins |
SG187173A1 (en) | 2010-07-30 | 2013-02-28 | Ac Immune Sa | Safe and functional humanized anti beta-amyloid antibody |
MX358739B (es) | 2010-08-14 | 2018-09-03 | Abbvie Inc Star | Proteinas de union a amiloide beta. |
EP3697927B1 (en) * | 2017-10-19 | 2022-12-14 | Bio-Rad Laboratories, Inc. | Digital amplification assays with unconventional and/or inverse changes in photoluminescence |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4666829A (en) * | 1985-05-15 | 1987-05-19 | University Of California | Polypeptide marker for Alzheimer's disease and its use for diagnosis |
JPH0779702B2 (ja) * | 1986-11-17 | 1995-08-30 | サイオス ノバ インコーポレイテッド | 組換えアルツハイマーアミロイドタンパク |
-
1987
- 1987-01-30 DE DE19873702789 patent/DE3702789A1/de not_active Withdrawn
-
1988
- 1988-01-15 US US07/144,297 patent/US5218100A/en not_active Expired - Lifetime
- 1988-01-19 KR KR1019880000751A patent/KR960011524B1/ko not_active IP Right Cessation
- 1988-01-19 DE DE88100647T patent/DE3886060D1/de not_active Expired - Fee Related
- 1988-01-19 EP EP88100647A patent/EP0276723B1/de not_active Expired - Lifetime
- 1988-01-19 AT AT88100647T patent/ATE98260T1/de not_active IP Right Cessation
- 1988-01-19 ES ES88100647T patent/ES2061527T3/es not_active Expired - Lifetime
- 1988-01-20 AU AU10641/88A patent/AU603179B2/en not_active Ceased
- 1988-01-27 NZ NZ223312A patent/NZ223312A/xx unknown
- 1988-01-27 IL IL85220A patent/IL85220A/xx not_active IP Right Cessation
- 1988-01-28 CA CA000557531A patent/CA1341033C/en not_active Expired - Fee Related
- 1988-01-29 JP JP63017539A patent/JP2783407B2/ja not_active Expired - Fee Related
- 1988-01-29 DK DK047588A patent/DK47588A/da not_active Application Discontinuation
- 1988-01-29 HU HU88412A patent/HUT46356A/hu unknown
- 1988-01-29 PH PH36426A patent/PH25795A/en unknown
- 1988-01-29 ZA ZA880634A patent/ZA88634B/xx unknown
- 1988-01-30 CN CN88100542A patent/CN1034576C/zh not_active Expired - Fee Related
-
1998
- 1998-01-16 JP JP02046398A patent/JP3513795B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA1341033C (en) | 2000-06-20 |
EP0276723A3 (de) | 1991-05-15 |
DK47588A (da) | 1988-07-31 |
ES2061527T3 (es) | 1994-12-16 |
JP2783407B2 (ja) | 1998-08-06 |
DE3886060D1 (de) | 1994-01-20 |
DK47588D0 (da) | 1988-01-29 |
PH25795A (en) | 1991-11-05 |
KR960011524B1 (ko) | 1996-08-23 |
EP0276723A2 (de) | 1988-08-03 |
JPH10218899A (ja) | 1998-08-18 |
NZ223312A (en) | 1991-10-25 |
ATE98260T1 (de) | 1993-12-15 |
US5218100A (en) | 1993-06-08 |
CN1034576C (zh) | 1997-04-16 |
AU603179B2 (en) | 1990-11-08 |
JPS63222693A (ja) | 1988-09-16 |
JP3513795B2 (ja) | 2004-03-31 |
AU1064188A (en) | 1988-08-04 |
DE3702789A1 (de) | 1988-08-18 |
ZA88634B (en) | 1988-08-02 |
IL85220A0 (en) | 1988-07-31 |
EP0276723B1 (de) | 1993-12-08 |
CN88100542A (zh) | 1988-08-10 |
KR880009035A (ko) | 1988-09-13 |
HUT46356A (en) | 1988-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL85220A (en) | Precursor protein of apc polypeptide and dna coding therefor | |
EP0787802A3 (xx) | ||
ZA889033B (en) | Vectors and compounds for direct expression of activated human protein c. | |
NO880268D0 (no) | Fremgangsmaate for fremstilling av anti-koagulerende peptider. | |
ATE184917T1 (de) | Rekombinante methode und wirt zur herstellung von xylitol | |
IT8522668A0 (it) | Procedimento per la preparazione di (2,2)-paraciclofani alogenati e miscele di (2,2)-paraciclofani alogenati ottenuti. | |
EP0209543A4 (en) | FRAGMENTS OF HUMAN APOLIPOPROTEINS PEPTIDES, TYPE-SPECIFIC ANTIBODIES AND METHODS OF USE. | |
HU902004D0 (en) | New trombolitic preparations | |
EP0373195A4 (en) | COMPOSITION FOR IN-VIVO OR IN-VITRO INCREASE IN MELANINE CONTENT OF THE MELANOCYTES AND THEIR USE IN-VITRO. | |
IT8419730A0 (it) | Procedimento per la trasformazione quantitativa di teicoplanina a2fattore 1 in teicoplanina a2fattore 3. | |
AU4267685A (en) | Tissue protein pp 18 | |
GR3015609T3 (en) | Vectors and compounds for expression of zymogen forms of human protein C. | |
AU564556B2 (en) | New p-phenylenediamine peptides and reactance containing themfor the determination of proteases of the blood coagulation system | |
IT8821049A0 (it) | Procedimento per l'alchilazione difenoli. | |
EP0315081A3 (en) | Anti-coagulating protein pp4-x, its preparation and use | |
GR3005231T3 (xx) | ||
PT79853B (en) | Process for the preparation of an highly solubilized protein | |
NZ224869A (en) | Recombinant plasmids coding for the htv coat protein (gag encoded proteins) and vaccines containing these proteins | |
PT86162A (en) | Recombinant protein expression | |
AU628903B2 (en) | Cdna coding for placenta protein 11 (pp11), the isolation and use thereof | |
AU5110390A (en) | Cdna coding for placental protein 9 (pp9), the isolation and use thereof | |
EP0331743A4 (en) | PROTEIN DERIVED FROM A LIVING BODY. | |
AU7506887A (en) | Medical or veterinary instrument | |
IT8622336A0 (it) | Procedimento per la preparazione di n-sulfamoilammidine e relativi intermedi. | |
IE873083L (en) | Tecombinant alzheimer's amyloid protein. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
RH | Patent void | ||
MM9K | Patent not in force due to non-payment of renewal fees |